Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

Keywords

Ovarian cancer, Breast cancer, Family history, Medicine, Oncology

References

• Population-based study of risk of breast cancer in carriers of BRCA2 mutation.María V. Seco Fernández, Álvaro González Hernández, Nicolás Pérez Hidalgo — 1998
• Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.Farah Katiria Sevilla González, Jorge Ocampo‐Candiani — 2001
• Change in the penetrance of founder BRCA1/2 mutations? A retrospective cohort studyAdria H. Katz — 2002
• Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.Ephrat Levy‐Lahad, Raphael Catane, Shlomit Eisenberg — 1997
• Modifiers of risk of hereditary breast and ovarian cancerSteven A. Narod — 2002
• Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele.Terri L. McGee, Marcella Devoto, Jürg Ott — 1997
• Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.Harvey A. Risch, John R. McLaughlin, David E.C. Cole — 2001
• Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.Timothy R. Rebbeck, Henry T. Lynch, Susan L. Neuhausen — 2002
• Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.Noah D. Kauff, Jaya M. Satagopan, Mark E. Robson — 2002
• Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.Hanne Meijers-Heijboer, Bert van Geel, Wim L.J. van Putten — 2001
• Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients.F Fodor, Ainsley Weston, Ira J. Bleiweiss — 1998
• The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%Carole Oddoux, Jeffery P. Struewing, C. Mark Clayton — 1996
• Effect of family history, obesity and exercise on breast cancer risk among postmenopausal womenCatherine L. Carpenter, Ronald K. Ross, Annlia Paganini‐Hill — 2003
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.Deborah Ford, Douglas F. Easton, Michael R. Stratton — 1998
• Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.Marcia S. Brose — 2002
• Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.Lauren Scheuer — 2002
• Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.Elizabeth Warner, William D. Foulkes, Pamela J. Goodwin — 1999
• The Statistical Analysis of Failure Time DataJohn P. Klein — 1980
• Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.Thomas Frank — 2002
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.Antonis C. Antoniou, Paul D.P. Pharoah, Steven A. Narod — 2003

Cited by

• Erblicher Brust- und EierstockkrebsDorothea Gadzicki, Alfons Meindl, Brigitte Schlegelberger — 2007
• Genetik des familiären Brust- und EierstockkrebsesAlfons Meindl, E. Hahnen, Norbert Arnold — 2014
• Das hereditäre MammakarzinomC. Crohns, Christoph Mundhenke — 2009
• A cross‐linker‐sensitive myeloid leukemia cell line from a 2‐year‐old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations尾中敦彦, 平方栄一, 渡瀬淳一郎 — 2005
• Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersMegan Fox — 2005
• A specific RAD51 haplotype increases breast cancer risk in Jewish non-Ashkenazi high-risk women.基成 小林, 俊博 鈴木, ラタポン サツトルサヤェン — 2006
• Cytotoxic activity of Fagonia cretica against human breast cancer cellsMatthew Lam — 2012
• Invited commentary: Physical activity, mortality, and genetics.Tuomo Rankinen, Claude Bouchard — 2007
• Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1-2 mutation carriers.Femi A. Aderohunmu — 2008
• Unraveling the Next Chapter: Sexual Development, Body Image, and Sexual Functioning in Female BRCA Carriers一生 三好 — 2009
• Factors associated with preimplantation genetic diagnosis acceptance among women concerned about hereditary breast and ovarian cancerSusan T. Vadaparampil, Gwendolyn P. Quinn, Caprice Knapp — 2009
• Cancer genetics and reproduction.José Ramón López de los Mozos Jiménez — 2010
• Expression of FANCD2 in sporadic breast cancer and clinicopathological analysisF. Fahroo — 2010
• Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.Arthur Wellington Holmes — 2011
• Hereditary ovarian cancer: recent molecular insights and their impact on screening strategiesMarisa del Olmo — 2011
• BRCA testing is important for our patients.Juan J Jiménez Osornio, Arturo Gómez Pompa — 2012
• 10 rare tumors that warrant a genetics referralClaude-Eric Parveaud, François Warlop — 2012
• Pituitary adenomas: Surgery and radiotherapy in the age of molecular diagnostics and pathology.А. Е. Будревич, Нина Александровна Нечипоренко — 2013
• Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivorsMargarita Huesca, Alicia Palacios‐Orueta, J. Litago Lavilla — 2013
• Epithelial cancers in the post-genomic era: should we reconsider our lifestyle?Elvio Bellini, Stefania Nin, L. Natarelli — 2013

Related papers

• Meta-analysis on the relationship between family history of tumor and the risk of breast cancer among Chinese womenLu Wen — 2012
• Are breast density and family history associated with pre-operative breast MRI use?Louise M. Henderson, Rebecca A. Hubbard, Karen J. Wernli — 2015
• Family history of breast cancer, mammographic breast density and breast cancer risk: Findings from a cohort study of Korean womenThị Xuân Mai Trần, Soyeoun Kim, Huiyeon Song — 2022
• Family history of breast cancer, mammographic features of breast tissue, and breast cancer risk.Jacques Brisson — 1991
• Family history of breast cancer and breast cancer risk in JapanMasao Kanamori, Takashi Fukutomi, Minoru Sugita — 1996
• Abstract P3-07-01: Family history of breast cancer in a population-based breast cancer cohort: No association with PAM50 intrinsic subtype or prognosisCarol Sweeney, PS Bernard, ML Kwan — 2013
• Interactions of Family History of Breast Cancer with Radiotherapy in Relation to the Risk of Breast Cancer RecurrenceDanmeng Li, Volker Mai, Travis Gerke — 2017
• High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history.Uziel Beller, David Halle, Raphael Catane — 1997
• Preoperative Breast Magnetic Resonance Imaging Use by Breast Density and Family History of Breast CancerLouise M. Henderson, Rebecca A. Hubbard, Weiwei Zhu — 2018